Roivant Sciences Ltd.
CIK 1635088 · last filed 2025-12-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$4.72B
Companies
6
Total Filings
34
Lifetime Open-Market Net
$940.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMVT | Director | 113,317,007 | $39.90 | $4.52B | $759.94M | 7 | 2025-12-12 |
| ABUS | 10%+ Owner | 38,847,462 | $5.09 | $197.73M | $0 | 3 | 2021-10-20 |
| Immunovant, Inc. (IMVTW) Delisted | 10%+ Owner | 47,213,419 | — | — | $15.00M | 3 | 2020-05-14 |
| Sio Gene Therapies Inc. (AXGT) Delisted | 10%+ Owner | 18,577,380 | — | — | $20.00M | 1 | 2020-02-27 |
| Urovant Sciences Ltd. (UROV) Delisted | 10%+ Owner | 22,860,013 | $16.24 | $371.25M | $38.75M | 10 | 2019-12-31 |
| Myovant Sciences Ltd. (MYOV) Delisted | 10%+ Owner | 44,895,145 | $26.98 | $1.21B | $106.37M | 7 | 2019-12-31 |
Recent Filings · Page 3 of 4
34 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-11 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +21,338 | $177.2K | EDGAR |
| 2019-06-06 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +21,122 | $166.0K | EDGAR |
| 2019-06-06 | Myovant Sciences Ltd. (MYOV) Delisted | Buy (P) | +2,424,242 | $20.00M | EDGAR |
| 2019-06-03 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +17,746 | $138.9K | EDGAR |
| 2019-05-29 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +14,485 | $110.5K | EDGAR |
| 2019-05-23 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +19,830 | $162.9K | EDGAR |
| 2019-05-20 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +21,608 | $162.9K | EDGAR |
| 2019-03-19 | — | Buy (P) | +6,666,667 | $10.00M | |
| 2018-12-20 | — | Buy (P) | +10,000,000 | $10.00M | |
| 2018-10-03 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +2,678,571 | $37.50M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.